Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Agios Pharmaceuticals (AGIO) Shares Repurchased (2021)

Agios Pharmaceuticals (AGIO) has disclosed Shares Repurchased for 1 consecutive years, with $19.0 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Shares Repurchased changed N/A year-over-year to $19.0 million, compared with a TTM value of $273.4 million through Dec 2022, changed 0.0%, and an annual FY2021 reading of $802.5 million, changed N/A over the prior year.
  • Shares Repurchased was $19.0 million for Q4 2021 at Agios Pharmaceuticals, down from $254.4 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $254.4 million in Q3 2021 and bottomed at $19.0 million in Q4 2021.